PLRX Pliant Therapeutics, Inc.
$1.17▲ +3.54%
Healthcare
Other
After hours
$1.17▲ +0.00%
Sep 11, 7:30 PM ET
Volume 173.5K
Avg Volume (10D) 404.5K
Key Metrics & Fundamentals
Market Cap
$72.45M
P/E Ratio
–
Div Yield
–%
52W Range
1.02 - 1.95
% vs 50 MA
5.52%
% vs 200 MA
-3.89%
RSI-14
56.6
MACD Histogram
+0.0000
Beta (1Y vs SPY)
1.04
Free Cash Flow
-$12.80M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$22.12M
COGS
–
Operating Exp
$23.86M
Operating Income
-$23.86M
EBIT
-$23.86M
Pretax Income
-$22.37M
Net Income
-$22.37M
EPS (Diluted)
-0.36
Price & Volume History
Loading chart…
Recent News
Pliant Therapeutics Receives FDA Fast Track Designation for PLN-101095 in Combination with Pembrolizumab for the Treatment of ICI-Refractory Solid Tumors
GlobeNewswire · Aug 18, 2026 12:30 PM
Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results
GlobeNewswire · Aug 11, 2026 8:05 PM
Pliant Therapeutics Names Flavia Borellini, Ph.D. and Robert Iannone, M.D., M.S.C.E. to Board of Directors
GlobeNewswire · Jul 13, 2026 12:30 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See PLRX's money flow as a full page
Social Sentiment
No Reddit posts found for PLRX.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.